Armour Residential REIT (ARR) Updates June 2025 Metrics

By Philip Seaworth • Monday, June 16 06:01 • Permanent Link

Armour Residential REIT, Inc. has released its monthly update for June 2025, providing key data as of 05/31/2025. Let's take a closer look at the changes and updates in the company's metrics since the last period.

Common Stock Price: The common stock price stands at $16.21, indicating a specific value for investors and potential shareholders.

Debt-Equity and Implied Leverage: The debt-equity ratio is 8.0, while the implied leverage is 8.3, showing the company's leverage position and its potential risk exposure.

Total Liquidity: Total liquidity has increased to $686.7 million, representing a 44% liquidity level of the total capital, potentially indicating a strengthened financial position.

Dividend Information: In June 2025, the common dividend is $0.24, providing insight into the returns for common shareholders.

Armour Portfolio: The portfolio composition includes various types of mortgage-backed securities (MBS), with notable percentages and current values.

Armour Repo Composition: The company's repo composition details the principal borrowed, the percentage of repo positions with Armour, and the weighted average remaining term, providing insight into its financing activities.

Armour Interest Rate Swaps: The interest rate swaps maturity, notional amount, weighted average remaining term, and weighted average rate provide a comprehensive view of the company's interest rate management strategies.

These specific metrics and changes in the company's financial position provide valuable insights for investors, analysts, and stakeholders to understand Armour Residential REIT, Inc.'s performance and financial health as of June 2025. Following these announcements, the company's shares moved 0.54%, and are now trading at a price of $16.90. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.